FoxM1 Regulates Proliferation and Apoptosis of Human Neuroblastoma Cell through PI3K/AKT Pathway

Role and toxicity of radiation therapy in neuroblastoma patients: A literature review

(2020) Qin Zhao et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

High expression of FOXM1 critical for sustaining cell proliferation in mitochondrial DNA-less liver cancer cells

(2020) Masato Higurashi et al.   EXPERIMENTAL CELL RESEARCH

Glucose-Dependent FOXM1 Promotes Epithelial-to-Mesenchymal Transition Via Cellular Metabolism and Targeting Snail in Human Pancreatic Cancer

(2020) Takuro Kyuno et al.   PANCREAS

Immunotherapy of Pediatric Solid Tumors: Treatments at a Crossroads, with an Emphasis on Antibodies

(2020) Dana L. Casey et al.   Cancer Immunology Research

Cancer Stem Cells in Pheochromocytoma and Paraganglioma

(2020) Laura D. Scriba et al.   Frontiers in Endocrinology

Monitoring Immune Responses in Neuroblastoma Patients during Therapy

(2020) Celina L. Szanto et al.   Cancers

FOXM1 facilitates breast cancer cell stemness and migration in YAP1-dependent manner

(2020) Hong-Liang Sun et al.   ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS

LncRNA MFI2-AS1 promotes HCC progression and metastasis by acting as a competing endogenous RNA of miR-134 to upregulate FOXM1 expression

(2020) Yongpeng Wei et al.   BIOMEDICINE & PHARMACOTHERAPY

Baicalin suppresses the cell cycle progression and proliferation of prostate cancer cells through the CDK6/FOXM1 axis

(2020) Ziqiang Yu et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

Role of PI3K/AKT pathway in cancer: the framework of malignant behavior

(2020) Ningni Jiang et al.   MOLECULAR BIOLOGY REPORTS

The PI3K/mTOR dual inhibitor GSK458 potently impedes ovarian cancer tumorigenesis and metastasis

(2020) Yangjiong Xiao et al.   CELLULAR ONCOLOGY

MYCN Silencing by RNA Interference Induces Neurogenesis and Suppresses Proliferation in Models of Neuroblastoma with Resistance to Retinoic Acid

(2020) Ruhina Maeshima et al.   Nucleic Acid Therapeutics

Loss of FOXM1 in macrophages promotes pulmonary fibrosis by activating p38 MAPK signaling pathway

(2020) Chinmayee Goda et al.   PLoS Genetics

Targeting the DNA Damage Response for the Treatment of High Risk Neuroblastoma

(2020) Harriet E. D. Southgate et al.   Frontiers in Oncology

Organoid Models of Glioblastoma to Study Brain Tumor Stem Cells

(2020) Roberta Azzarelli   Frontiers in Cell and Developmental Biology

Developmental origins and oncogenic pathways in malignant brain tumors

(2019) Q. Richard Lu et al.   Wiley Interdisciplinary Reviews-Developmental Biology

Recent nanotechnological interventions targeting PI3K/Akt/mTOR pathway: A focus on breast cancer

(2019) VarRuchi Sharma et al.   SEMINARS IN CANCER BIOLOGY

FOXM1 drives proximal tubule proliferation during repair from acute ischemic kidney injury

(2019) Monica Chang-Panesso et al.   JOURNAL OF CLINICAL INVESTIGATION

De novo regulation of RD3 synthesis in residual neuroblastoma cells after intensive multi-modal clinical therapy harmonizes disease evolution

(2019) Dinesh Babu Somasundaram et al.   Scientific Reports

Integrated Network Analysis Reveals FOXM1 and MYBL2 as Key Regulators of Cell Proliferation in Non-small Cell Lung Cancer

(2019) Firoz Ahmed   Frontiers in Oncology

SKP2 Promotes Hepatocellular Carcinoma Progression Through Nuclear AMPK-SKP2-CARM1 Signaling Transcriptionally Regulating Nutrient-Deprived Autophagy Induction

(2018) Xiaoshuang Wei et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Chronic exposure to microcystin-leucine-arginine promoted proliferation of prostate epithelial cells resulting in benign prostatic hyperplasia

(2018) Chun Pan et al.   ENVIRONMENTAL POLLUTION

Minute Virus of Mice Inhibits Transcription of the Cyclin B1 Gene during Infection

(2017) Matthew S. Fuller et al.   JOURNAL OF VIROLOGY

Roles of FoxM1 in cell regulation and breast cancer targeting therapy

(2017) Xin Song et al.   MEDICAL ONCOLOGY

The PI3K/AKT Pathway as a Target for Cancer Treatment

(2016) Ingrid A. Mayer et al.   Annual Review of Medicine

Skp2 is over-expressed in breast cancer and promotes breast cancer cell proliferation

(2016) Wenwen Zhang et al.   CELL CYCLE

Prognostic Value of FOXM1 in Patients with Malignant Solid Tumor: A Meta-Analysis and System Review

(2015) Jun Dai et al.   DISEASE MARKERS

Silibinin-induced glioma cell apoptosis by PI3K-mediated but Akt-independent downregulation of FoxM1 expression

(2015) Mingjie Zhang et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Investigation of FOXM1 as a Potential New Target for Melanoma

(2015) Azusa Miyashita et al.   PLoS One

Effects of metformin on FOXM1 expression and on the biological behavior of acute leukemia cell lines

(2014) BING ZHANG et al.   Molecular Medicine Reports

FOXM1: A key oncofoetal transcription factor in health and disease

(2014) Laura Bella et al.   SEMINARS IN CANCER BIOLOGY

Knockdown of β-catenin expression inhibits neuroblastoma cell growth in vitro and in vivo

(2013) Wei Yao et al.   JOURNAL OF PEDIATRIC SURGERY

From quiescence to proliferation: Cdk oscillations drive the mammalian cell cycle

(2012) Claude Gérard et al.   Frontiers in Physiology

FoxM1 in Tumorigenicity of the Neuroblastoma Cells and Renewal of the Neural Progenitors

(2011) Z. Wang et al.   CANCER RESEARCH